Allergen-specific immunotherapy for atopic dermatitis: current status, problems and prospects
Russian Journal of Allergy · 06.05.2026 · 23 (2) · 221-228
DOI: 10.36691/rja17121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Journal of Allergy, online erschienen am 06.05.2026. Verfasst von Valeriia S. Iuzhaninova und 5 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Atopic dermatitis is one of the most common skin diseases (accounting for 20 to 40 %) and occurs in individuals of both sexes and across different age groups. The disease can significantly reduce quality of life, including serving as a cause of social maladaptation; therefore, the issue of studying effective methods for the treatment of atopic dermatitis remains relevant, aimed at minimizing its manifestations and prolonging periods of remission. The key components of the pathogenesis of atopic dermatitis are impairment of the skin barrier function, chronic T2-inflammation, and the development of immunoglobulin E specific sensitization to allergens. Along with allergic rhinitis and bronchial asthma, atopic dermatitis belongs to T2-associated diseases, for which one of the treatment options is allergen-specific immunotherapy. This method has proven successful in the treatment of atopic diseases and, due to its disease-modifying effect, the issue of its efficacy and safety in patients with atopic dermatitis has been actively studied in recent years. This review summarizes current data on the use of allergen-specific immunotherapy with house dust mite allergens in patients with atopic dermatitis and presents a case report illustrating the successful use of allergen-specific immunotherapy with house dust mites allergen in a patient with atopic comorbidities.
Zitieren
APA
Iuzhaninova, V. S., Elisyutina, O. G., Smolnikov, E. V., Fedenko, E. S., Ilyina, N. I., & Kleiner, D. V. (2026). Allergen-specific immunotherapy for atopic dermatitis: current status, problems and prospects. Russian Journal of Allergy, 23(2), 221-228. https://doi.org/10.36691/rja17121
Vancouver
Iuzhaninova VS, Elisyutina OG, Smolnikov EV, Fedenko ES, Ilyina NI, Kleiner DV. Allergen-specific immunotherapy for atopic dermatitis: current status, problems and prospects. Russian Journal of Allergy. 2026;23(2):221-228. doi:10.36691/rja17121
BibTeX
@article{Iuzhaninova2026,
author = {Iuzhaninova, Valeriia S. and Elisyutina, Olga G. and Smolnikov, Evgeniy V. and Fedenko, Elena S. and Ilyina, Natalya I. and Kleiner, Dina V.},
title = {Allergen-specific immunotherapy for atopic dermatitis: current status, problems and prospects},
journal = {Russian Journal of Allergy},
year = {2026},
volume = {23},
number = {2},
pages = {221--228},
doi = {10.36691/rja17121}
}
EUVIMED